PMC:7278327 / 987-1291
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T9 | 149-157 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
| T10 | 201-204 | Body_part | denotes | HIV | http://purl.org/sig/ont/fma/fma278683 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 37 | 243-251 | Species | denotes | MERS-CoV | Tax:1335626 |
| 38 | 270-287 | Species | denotes | hepatitis C virus | Tax:11103 |
| 41 | 27-31 | Species | denotes | RABV | Tax:11292 |
| 42 | 107-111 | Species | denotes | RABV | Tax:11292 |
| 43 | 289-292 | Species | denotes | HCV | Tax:11103 |
| 51 | 175-241 | Disease | denotes | immunodeficiency virus 1 (HIV-1), Middle East respiratory syndrome | MESH:D018352 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T13 | 175-191 | Disease | denotes | immunodeficiency | http://purl.obolibrary.org/obo/MONDO_0021094 |
| T14 | 270-281 | Disease | denotes | hepatitis C | http://purl.obolibrary.org/obo/MONDO_0005231 |
| T15 | 270-279 | Disease | denotes | hepatitis | http://purl.obolibrary.org/obo/MONDO_0002251 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T17 | 32-35 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T18 | 169-174 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
| T19 | 192-197 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T20 | 282-287 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T4 | 149-157 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T8 | 0-304 | Sentence | denotes | Genetic engineering of the RABV has been employed to generate novel vaccines consisting of non-replicating RABV particles expressing chimeric capsid proteins containing human immunodeficiency virus 1 (HIV-1), Middle East respiratory syndrome (MERS-CoV), Ebolavirus, and hepatitis C virus (HCV) sequences. |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 175-191 | Phenotype | denotes | immunodeficiency | http://purl.obolibrary.org/obo/HP_0002721 |
| T2 | 270-279 | Phenotype | denotes | hepatitis | http://purl.obolibrary.org/obo/HP_0012115 |